Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05109208

The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction

Conditions: Prostate Adenocarcinoma

Sex: Male
Ages: 40 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: Mayo Clinic

Location: Mayo Clinic in Rochester Rochester Minnesota

Summary

Researchers are trying to determine whether there is additional utility to using vibroelastography, a noninvasive ultrasound technique to evaluate for the presence of tissue fibrosis, in conjunction with standard penile duplex Doppler ultrasound to assess erectile function (recovery) after prostate cancer surgery.

Eligibility Criteria

Inclusion criteria include: * Age \> 40 years * Clinically localized prostate cancer (American Urological Association Grade Groups 1-2; cT1c or cT2a-b; PSA \< 10) without clinic or imaging evidence of localized extra-prostatic or metastatic disease (i.e. AUA low and favorable intermediate risk prostate cancer) * International Index of Erectile Function (IIEF) of ≥ 21 points at baseline (no or mild erectile dysfunction) * Patient-expressed interest in consultation for sexual function (erectile function) preservation/ optimization * Planned bilateral nerves-paring prostatectomy Exclusion criteria include: * Moderate or severe ED based in IIEF criteria (score \< 21) * History of prior pelvic or penile surgery * Current or prior androgen deprivation therapy * Planned non-nerve sparing prostatectomy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05109208). StuddyBuddy aggregates publicly available trial information.